Showing results (291-300 of 454) with videos related to

Sort By:
Pageof 46
Clinical Lymphoma, Myeloma & Leukemia|October 8, 2013
Vinorelbine, paclitaxel, etoposide, cisplatin, and cytarabine (VTEPA) is an effective second salvage therapy for relapsed/refractory Hodgkin lymphomaRajni Sinha, Pareen J Shenoy, Nassoma King, et al.
Blood Advances|April 12, 2021
Transfer to the clinic: refining forward programming of hPSCs to megakaryocytes for platelet production in bioreactorsAmanda L Evans, Amanda Dalby, Holly R Foster, et al.
Ophthalmology Science|October 17, 2022
A Randomized Trial of Topical Fibrinogen-Depleted Human Platelet Lysate Treatment of Dry Eye Secondary to Chronic Graft-versus-Host DiseaseAlan Sugar, Munira Hussain, Winston Chamberlain, et al.
Blood Advances|August 28, 2025
Efficacy and Safety of Belumosudil as Compared with Best Available Therapy for the Treatment of cGVHD in the USKevin Hall, Aleksandr Lazaryan, Mark van Der Laan, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 20, 2025
Plasma Cytokine and Chemokine Profiles Predict Efficacy and Toxicity of Anti-CD19 CAR-T Cell Therapy in Large B-Cell LymphomaFanyuan Zeng, Hanwen Zhang, Shuhua Wang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 11, 2014
Pharmacoeconomic analysis of palifermin to prevent mucositis among patients undergoing autologous hematopoietic stem cell transplantationAjay K Nooka, Heather R Johnson, Jonathan L Kaufman, et al.
Journal of Psychosomatic Research|January 28, 2024
Acute psychological stress-induced progenitor cell mobilization and cardiovascular eventsZakaria Almuwaqqat, Matthew Wittbrodt, Kasra Moazzami, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 23, 2015
Combination of GM-CSF With Fludarabine-Containing Regimens in Chronic Lymphocytic Leukemia and Indolent Non-Hodgkin LymphomaJonathon B Cohen, Silvana Bucur, Elliott F Winton, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 2, 2019
Ibrutinib for Chronic Graft-versus-Host Disease After Failure of Prior Therapy: 1-Year Update of a Phase 1b/2 StudyEdmund K Waller, David Miklos, Corey Cutler, et al.
Blood|April 6, 2011
Impact of immune modulation with anti-T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignanciesRobert J Soiffer, Jennifer Lerademacher, Vincent Ho, et al.
Pageof 46